Analysis of Age Factor and Hemoglobin Profiles in The Incidence of Uterine Leiomyoma

Analysis of Age Factor and Hemoglobin Profiles in The Incidence of Uterine Leiomyoma DOI: https://doi.org/10.26630/jk.v16i3.5393Keywords: Anemia, Benign, Demographic, Uterine tumor, Risk factorsAbstract Uterine leiomyoma is recognized as the most common benign tumor of the female reproductive system and remains a significant cause of gynecological morbidity worldwide. Its development has been closely associated with hormonal exposure, particularly estrogen and progesterone, and with reproductive age. Despite being frequently encountered in clinical practice, the role of other contributing factors, such as hemoglobin status, remains less clear. This study examined the relationships among age, hemoglobin concentration, and the incidence of uterine leiomyoma. An observational-analytic case-control design, using leiomyoma as cases and adenomyosis as controls, was conducted at PKU Muhammadiyah Hospital, Surakarta. A total of 246 participants were included, comprising 93 women with histopathologically confirmed leiomyoma and 153 women with adenomyosis as the control group. Data were obtained from hospital medical records, and statistical analyses were performed using Chi-square tests followed by logistic regression. The results demonstrated that being in the reproductive age group (≤50 years) significantly increased the likelihood of leiomyoma occurrence (OR=3.114, 95%CI: 1.141–8.500, p=0.021). In contrast, hemoglobin profiles did not show a significant association with leiomyoma incidence (OR=0.777, 95%CI: 0.428–1.441, p=0.407). Although anemia was frequently observed in both groups, it appeared more likely to be a clinical manifestation of abnormal uterine bleeding than a direct etiological factor. References Adriani, P., Harapan, S., Purwokerto, B. (2018). Analisis Regresi Faktor Resiko Kejadian Mioma Uteri di RSUD dr. R. Goeteng Tarunadibrata Purbalingga. Indonesian Journal of Nursing Research, 1(1), 39–47. https://doi.org/10.35473/ijnr.v1i1.7 Alali, O.M., Churnosov, M.I. (2023). The Etiopathogenesis of Uterine Leiomyomas: A Review. Gynecology, 25(1), 22–30. https://doi.org/10.26442/20795696.2023.1.201827 Alemari, N.B.A., Kaplanoglu, G.T. (2022). Current Understanding of Pathogenesis, Histopathology, Diagnosis, and Treatment Options of Uterine Fibroids-Review. Journal of Gazi University Health Science Institute, 4. Alfarizan, R., & Marindawati, M. (2020). Hubungan antara Perempuan Usia Reproduksi dengan Kejadian Leiomioma Uteri dan Adenomiosis Uteri di Rumah Sakit Umum Daerah Cengkareng Jakarta Barat Tahun 2017-2019. Muhammadiyah Journal of Midwifery, 1(1), 19-24. https://doi.org/10.24853/myjm.1.1.19-24 Antunes, D., Gante, I., Carvalho, M.J., Medeiros-Borges, C., Águas, F. (2022). The impact of anemia on treatment management and clinical outcomes of women hospitalized for uterine leiomyomas. Ginekol Pol 93, 799–805. https://doi.org/10.5603/GP.a2022.0086 Arifint, H., Wagey, F., M Tendean, H.M., Ratulangi Manado, S. (2019). Karakteristik Penderita Mioma Uteri di Rsup Prof. Dr. R.D. Kandou Manado. Jurnal Medik dan Rehabilitasi (JMR), 1(3), 1-6. https://ejournal.unsrat.ac.id/index.php/jmr/article/view/22540 Azhari, F., Ahmad Rasas, B., Wibowo, N. (2024). Leiomioma Uteri Besar pada Wanita dengan Grande Multipara dan Pasca-Menopause di Rumah Sakit Umum Daerah Ciamis: Sebuah Laporan Kasus. Indonesian Journal of Obstetrics & Gynecology Science, 7(1), 55–62. https://doi.org/10.24198/obgynia.v7i1.633 Delli Carpini, G., Morini, S., Papiccio, M., Serri, M., Damiani, V., Grelloni, C., ... & Ciavattini, A. (2019). The association between childbirth, breastfeeding, and uterine fibroids: an observational study. Scientific Reports, 9(1), 10117. https://doi.org/10.1038/s41598-019-46513-0 Dimauro, A.R., Dahal, A., Okeke, I., Lerman, I., Amitrano, A., Seger, C., Kumar, D., Bhagavath, B., Taya, M., Hammes, S.R. (2020). Reproductive Endocrinology Clinical Studies In Female Reproduction I Prolactin Is Expressed in Uterine Leiomyomas and May Promote Their Growth. Journal of the Endocrine Society, Volume 4, Issue Supplement 1. https://doi.org/10.1210/jendso/bvaa046.657 Farma, A.F.F., Kurniati, Y.P. (2024). Analysis of The Incidence of Uterine Leiomyoma Based on Body Mass Index and Neutrophil-Lymphocyte Ratio. Journal La Medihealtico 5, 998–1007. https://doi.org/10.37899/journallamedihealtico.v5i5.1609 Goad, J., Rudolph, J., Zandigohar, M., Tae, M., Dai, Y., Wei, J.J., Bulun, S.E., Chakravarti, D., Rajkovic, A. (2022). Single-cell sequencing reveals novel cellular heterogeneity in uterine leiomyomas. Human Reproduction 37, 2334–2349. https://doi.org/10.1093/humrep/deac183 Gustiari, I., Riyandi, N. A., & Harahap, A. (2023). Total Abdominal Histerektomi dan Bilateral Salpingo Ooforektomi pada Mioma Uteri: Sebuah Laporan Kasus. Jurnal Kedokteran Nanggroe Medika, 6(2), 75-82. https://jknamed.com/jknamed/article/view/269 Hartoyo, A., Pangastuti, N. (2022). Fibroid Uterus dan Infertilitas. CKD-302, 49(3), 143-146. https://doi.org/10.55175/cdk.v49i3.208 Ishikawa, H., Kobayashi, T., Kaneko, M., Saito, Y., Shozu, M., Koga, K. (2023). Role of MED12 mutation in the pathogenesis of uterine fibroids. J Mol Endocrinol, 71(4). https://doi.org/10.1530/JME-23-0039 Kurniati, Y.P., Romadhon, Y.A., Parawansa, K.I. (2024). Analysis Of Adenomyosis Incidence Based On Age And Neutrophil Lymphocyte Ratio Factors. Jurnal Of Health Studies, 8(1), 37–45. https://doi.org/10.31101/jhes.3536 Maclean, J.A., Hayashi, K. (2022). Progesterone Actions and Resistance in Gynecological Disorders. Cells, 11, 647. https://doi.org/10.3390/cells11040647 Madendag, Y., Sahin, E., Aydin, E., Col Madendag, I., Acmaz, G., Karaman, H. (2018). Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Can Be Useful Markers for Distinguishing Uterine Adenomyosis from Leiomyoma. Gynecology Obstetrics & Reproductive Medicine, 24, 147–150. https://doi.org/10.21613/gorm.2017.716 Maekawa, R., Sato, S., Tamehisa, T., Sakai, T., Kajimura, T., Sueoka, K., Sugino, N. (2022). Different DNA methylome, transcriptome, and histological features in uterine fibroids with and without MED12 mutations. Sci Rep 12. https://doi.org/10.1038/s41598-022-12899-7 Marcellina, C., & Pramana, C. (2023). Laparotomi miomektomi mioma uteri wanita usia 48 tahun: laporan kasus. Jurnal Kesehatan Reproduksi, 10(1). https://doi.org/10.22146/jkr.81854 McWilliams, M.M., Chennathukuzhi, V.M. (2017). Recent Advances in Uterine Fibroid Etiology. Semin Reprod Med 35, 181–189. https://doi.org/10.1055/s-0037-1599090 Meilani, N.S., Firdaus Mansoer, F.A., Nur, I.M., Argadireja, D.S. (2019). Artikel Penelitian Hubungan Usia Dan Paritas Dengan Kejadian Mioma Uteri Di RSUD Al-Ihsan Provinsi Jawa Barat Tahun 2017. Jurnal Integrasi Kesehatan & Sains, 2(1), 200-203. http://ejournal.unisba.ac.id/index.php/jiks/article/view/4346 Micić, J., Macura, M., Andjić, M., Ivanović, K., Dotlić, J., Micić, D.D., Arsenijević, V., Stojnić, J., Bila, J., Babić, S., Šljivančanin, U., Stanišić, D.M., Dokić, M., (2024). Currently Available Treatment Modalities for Uterine Fibroids. Medicina (Lithuania), 60, 868. https://doi.org/10.3390/medicina60060868 Navarro, A., Bariani, M. V., Yang, Q., & Al-Hendy, A. (2021). Understanding the impact of uterine fibroids on human endometrium function. Frontiers in cell and developmental biology, 9, 633180. https://doi.org/10.3389/fcell.2021.633180 Nizomy, I.R., Budinurdjaja, P., Armanza, F., Yuseran, H., Joyce, L., I.T.F. (2024). Early diagnosis and appropriate management of vaginal leiomyoma in rural areas. Majalah Obstetri & Ginekologi 32, 60–67. https://doi.org/10.20473/mog.v32i12024.60-67 Romadhon, Y.A., Kurniati, Y.P. (2024). Pathway Pengaruh Lingkungan Dalam Inisiasi Dan Progresivitas Kanker Tulang Dan Jaringan Lunak. Muhammadiyah University Press, 1st Ed. Safiri, S., Kolahi, A. A., Noori, M., Nejadghaderi, S. A., Karamzad, N., Bragazzi, N. L., ... & Grieger, J. A. (2021). Burden of anemia and its underlying causes in 204 countries and territories, 1990–2019: results from the Global Burden of Disease Study 2019. Journal of hematology & oncology, 14(1), 185. https://doi.org/10.1186/s13045-021-01202-2 Umar, M., Palinggi, M., Syahadat, D.S., Aiman, U. (2023). Faktor Risiko Kejadian Mioma Uteri Pada Pasien Rawat Jalan di RSUD Undata Provinsi Sulawesi Tengah. Ghidza: Jurnal Gizi dan Kesehatan 7, 245–259. https://doi.org/10.22487/ghidza.v7i2.872 Vannuccini, S., Petraglia, F., Carmona, F., Calaf, J., & Chapron, C. (2024). The modern management of uterine fibroids-related abnormal uterine bleeding. Fertility and Sterility, 122(1), 20-30. https://doi.org/10.1016/j.fertnstert.2024.04.041 Zulala, N. N. (2024). Faktor-faktor yang berhubungan dengan kejadian mioma uteri di RS PKU Muhammadiyah Gamping, Sleman Yogyakarta. In Prosiding Seminar Nasional Penelitian dan Pengabdian Kepada Masyarakat LPPM Universitas' Aisyiyah Yogyakarta (Vol. 2, pp. 1220-1228). https://proceeding.unisayogya.ac.id/index.php/prosemnaslppm/article/view/953 Downloads Published Issue Section License Copyright (c) 2025 Nugrahani Putri Tyas Paramarta, Yuni Prastyo Kurniati This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish in this journal agree to the following terms: - Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. - Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal. - Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as this can lead to productive exchanges and earlier and greater citations of published work.